GI-2025-26-reg4: Order Repealing the Order Establishing Supplementary Rules Respecting the Sale of Natural Health Products Containing Ephedrine or Pseudoephedrine

Businesses that sell natural health products containing ephedrine or pseudoephedrine — such as health supplement retailers, pharmacies, and natural health product manufacturers — will no longer be subject to the supplementary sales rules under the repealed order. Instead, these products will fall under the updated Precursor Control Regulations, which are expected to impose increased regulatory oversight. The full details of compliance costs and the number of affected businesses are contained in the RIAS for the Regulations Amending the Precursor Control Regulations (Increased Regulatory Oversight), which serves as the primary impact analysis for this repeal. Businesses in this space should review those amending regulations to understand their new obligations going forward.